PMC:7652766 / 26831-27230 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":101,"end":110},"obj":"Phenotype"},{"id":"T27","span":{"begin":143,"end":163},"obj":"Phenotype"},{"id":"T28","span":{"begin":188,"end":193},"obj":"Phenotype"},{"id":"T29","span":{"begin":379,"end":398},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0031273"},{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0002878"}],"text":"Most COVID-19 patients exhibit mild to moderate symptoms, but approximately 15% progress to critical pneumonia and 5% eventually develop acute respiratory distress syndrome (ARDS), septic shock, multiple organ failure, and death (26, 108). Once the infection is installed, the spectrum of clinical presentations has been reported to range from asymptomatic infection to critical respiratory failure."}

{"project":"LitCovid-sentences","denotations":[{"id":"T137","span":{"begin":0,"end":239},"obj":"Sentence"},{"id":"T138","span":{"begin":240,"end":399},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Most COVID-19 patients exhibit mild to moderate symptoms, but approximately 15% progress to critical pneumonia and 5% eventually develop acute respiratory distress syndrome (ARDS), septic shock, multiple organ failure, and death (26, 108). Once the infection is installed, the spectrum of clinical presentations has been reported to range from asymptomatic infection to critical respiratory failure."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1035","span":{"begin":367,"end":369},"obj":"Gene"},{"id":"1036","span":{"begin":330,"end":332},"obj":"Gene"},{"id":"1037","span":{"begin":89,"end":91},"obj":"Gene"},{"id":"1038","span":{"begin":36,"end":38},"obj":"Gene"},{"id":"1039","span":{"begin":14,"end":22},"obj":"Species"},{"id":"1040","span":{"begin":5,"end":13},"obj":"Disease"},{"id":"1041","span":{"begin":101,"end":110},"obj":"Disease"},{"id":"1042","span":{"begin":137,"end":172},"obj":"Disease"},{"id":"1043","span":{"begin":174,"end":178},"obj":"Disease"},{"id":"1044","span":{"begin":181,"end":193},"obj":"Disease"},{"id":"1045","span":{"begin":195,"end":217},"obj":"Disease"},{"id":"1046","span":{"begin":223,"end":228},"obj":"Disease"},{"id":"1047","span":{"begin":249,"end":258},"obj":"Disease"},{"id":"1048","span":{"begin":357,"end":366},"obj":"Disease"},{"id":"1049","span":{"begin":379,"end":398},"obj":"Disease"}],"attributes":[{"id":"A1035","pred":"tao:has_database_id","subj":"1035","obj":"Gene:6999"},{"id":"A1036","pred":"tao:has_database_id","subj":"1036","obj":"Gene:6999"},{"id":"A1037","pred":"tao:has_database_id","subj":"1037","obj":"Gene:6999"},{"id":"A1038","pred":"tao:has_database_id","subj":"1038","obj":"Gene:6999"},{"id":"A1039","pred":"tao:has_database_id","subj":"1039","obj":"Tax:9606"},{"id":"A1040","pred":"tao:has_database_id","subj":"1040","obj":"MESH:C000657245"},{"id":"A1041","pred":"tao:has_database_id","subj":"1041","obj":"MESH:D011014"},{"id":"A1042","pred":"tao:has_database_id","subj":"1042","obj":"MESH:D012128"},{"id":"A1043","pred":"tao:has_database_id","subj":"1043","obj":"MESH:D012128"},{"id":"A1044","pred":"tao:has_database_id","subj":"1044","obj":"MESH:D012772"},{"id":"A1045","pred":"tao:has_database_id","subj":"1045","obj":"MESH:D009102"},{"id":"A1046","pred":"tao:has_database_id","subj":"1046","obj":"MESH:D003643"},{"id":"A1047","pred":"tao:has_database_id","subj":"1047","obj":"MESH:D007239"},{"id":"A1048","pred":"tao:has_database_id","subj":"1048","obj":"MESH:D007239"},{"id":"A1049","pred":"tao:has_database_id","subj":"1049","obj":"MESH:D012131"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Most COVID-19 patients exhibit mild to moderate symptoms, but approximately 15% progress to critical pneumonia and 5% eventually develop acute respiratory distress syndrome (ARDS), septic shock, multiple organ failure, and death (26, 108). Once the infection is installed, the spectrum of clinical presentations has been reported to range from asymptomatic infection to critical respiratory failure."}